Plasma Plasminogen Activator Inhibitor-1 as a Biomarker for Disease Activity and Pharmaco-Response Prediction in Pediatric Epilepsy: A Prospective Cohort Study. [PDF]
Xiao X +7 more
europepmc +1 more source
The Double-Edged Sword Effect of the Fibrinolytic System in Alzheimer's Disease. [PDF]
Tang M, Liang M, Zhang X, Hong C, Ye L.
europepmc +1 more source
The Plasminogen Activation System in the Central Nervous System: Implications for Epilepsy and Neuropsychiatric Disorders. [PDF]
Suleymanova E, Karan A.
europepmc +1 more source
Structure-function relationships in the omptin family of enterobacterial proteases/adhesins [PDF]
Kukkonen, Maini
core
Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases. [PDF]
Liu RM, Nakamya MF.
europepmc +1 more source
Revisiting the Concept of DIC: A Phenotype-guided Framework for Modern Hemostatic Medicine. [PDF]
Crochemore T, Scarlatescu E.
europepmc +1 more source
Free flap salvage via direct urokinase injection into thrombosed veins: a case report. [PDF]
Hayashi M +5 more
europepmc +1 more source
Thrombolytic agents, more options, more challenges. [PDF]
Dong Y +9 more
europepmc +1 more source
Activated eosinophil plays a role in promoting fibrosis in endometriotic lesion. [PDF]
Ono Y +12 more
europepmc +1 more source
Related searches:
TISSUE plasminogen activator (t-PA) is a naturally occurring protein that catalyzes the conversion of the inactive proenzyme plasminogen into the active serine protease plasmin.
John A. Oates +3 more
openaire +2 more sources

